Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague

Infect Immun. 1995 Aug;63(8):2854-8. doi: 10.1128/iai.63.8.2854-2858.1995.

Abstract

The gene encoding V antigen from Yersinia pestis was cloned into the plasmid expression vector pGEX-5X-2. When electroporated into Escherichia coli JM109, the recombinant expressed V antigen as a stable fusion protein with glutathione S-transferase. The glutathione S-transferase-V fusion protein was isolated from recombinant E. coli and cleaved with factor Xa to yield purified V antigen as a stable product. Recombinant V antigen was inoculated intraperitoneally into mice and shown to induce a protective immune response against a subcutaneous challenge with 3.74 x 10(6) CFU of virulent Y. pestis. Protection correlated with the induction of a high titer of serum antibodies and a T-cell response specific for recombinant V antigen. These results indicate that V antigen should be a major component of an improved vaccine for plague.

MeSH terms

  • Animals
  • Antibodies, Bacterial / biosynthesis
  • Antigens, Bacterial / immunology*
  • Base Sequence
  • DNA Primers / chemistry
  • Female
  • Genes, Bacterial
  • Mice
  • Mice, Inbred BALB C
  • Molecular Sequence Data
  • Plague / prevention & control*
  • Pore Forming Cytotoxic Proteins
  • Recombinant Fusion Proteins
  • Vaccines, Synthetic
  • Yersinia pestis / immunology*

Substances

  • Antibodies, Bacterial
  • Antigens, Bacterial
  • DNA Primers
  • LcrV protein, Yersinia
  • Pore Forming Cytotoxic Proteins
  • Recombinant Fusion Proteins
  • Vaccines, Synthetic